ライフサイエンスコーパス: dermatology

1 ed to achieve universal imaging standards in dermatology.

2 highlighting recent studies in the field of dermatology.

3 lications for this technique in the field of dermatology.

4 tools can be applied to drug development in dermatology.

5 consultation for improving patient access to dermatology.

6 r clinical applications of gene therapies in dermatology.

7 ould be considered as potential new drugs in dermatology.

8 n to age and treatments in a local clinic of dermatology.

9 discovery with a focus on application within dermatology.

10 ogy, neurology, musculoskeletal biology, and dermatology.

11 bservational studies have important roles in dermatology.

12 sciplines: cell biology, mouse genetics, and dermatology.

13 t frequently used anti-inflammatory drugs in dermatology.

14 been considered unreliable for inference in dermatology.

15 ures were performed in the specialty area of dermatology.

16 r this new and dynamic era of data intensive dermatology.

17 diagnostic, and therapeutic interventions in dermatology.

18 estigators across multiple fields, including dermatology.

19 se series from a private practice (Hollywood Dermatology), 2 patients presented for dermatologic proc

20 agement published by the American Academy of Dermatology 2014 work group were compared with those cre

21 was in psychiatry (92.6%) and the lowest in dermatology (61.9%).

22 ics of each product (eg, American Academy of Dermatology [AAD] criteria, sun protection factor [SPF],

23 QI assessment tools.Journal of Investigative Dermatology accepted article preview online, 08 October

24 e PAR2-TSLP pathway.Journal of Investigative Dermatology accepted article preview online, 22 Septembe

25 applications in man.Journal of Investigative Dermatology accepted article preview online, 22 Septembe

26 d cancer resistance.Journal of Investigative Dermatology accepted article preview online, 30 Septembe

27 advanced cSCC carried out in 1 department of dermatology and 2 departments of medical oncology in Fra

28 far prevented its widespread adoption beyond dermatology and a few other oncological applications in

29 n experts in the field of allergy/immunology/dermatology and anaesthesiology is needed to provide the

30 ed by the Journal of the American Academy of Dermatology and Dermatology Times, respectively.

31 s of CRISPR genetic screens in investigative dermatology and how they may be used to answer key scien

32 Tertiary allergy, dermatology and paediatric units in 10 European countrie

33 pendent, self-selected academic and military dermatology and plastic surgery physicians with extensiv

34 between 2006 and 2009 from the Department of Dermatology and Rheumatology at the Radboud University M

35 ated with MMS or WLE per standard of care in dermatology and surgery (general surgery, otolaryngology

36 rral centers, as well as several pneumology, dermatology, and internal medicine departments.

37 ciety for Allergology, Society for Pediatric Dermatology, and World Allergy Organization.

38 Examples of each technique's use in dermatology are provided.

39 were all outpatients from the department of dermatology at Bispebjerg Hospital.

40 ive study was conducted at the department of dermatology at Ghent University Hospital between Februar

41 ts with advanced cancer who were referred to dermatology at Yale-New Haven Hospital, a tertiary care

42 conducted in a tertiary referral center for dermatology between January 1, 2009, and December 31, 20

43 re published in the Journal of Investigative Dermatology, but many articles from the broader scientif

44 pecialty performed better than optometry and dermatology, but worse than otolaryngology and urology,

45 studies took the fields of cell biology and dermatology by storm in providing the first credible evi

46 eledermatology appeared to improve access to dermatology care among Medicaid enrollees and played an

47 Follow-up in a specialized transplant dermatology center and baseline total-body skin examinat

48 hart review of all PLC visits at an academic dermatology center from October 2010 to January 2012.

49 cal trial of 30 patients from the outpatient dermatology center of Tufts Medical Center, enrolled fro

50 d evaluated at an academic tertiary referral dermatology center.

51 trial in a single-center outpatient academic dermatology center.

52 study was performed in 2 academic outpatient dermatology centers and 1 private dermatology practice.

53 tudinal Assessment and Registry [PSOLAR]) at dermatology centers.

54 r of pigmented lesion clinic (PLC) visits at dermatology centers.

55 rapy, were enrolled from 122 investigational dermatology centres worldwide.

56 to prednisolone from 54 UK and seven German dermatology centres.

57 ital Oakland, Columbia University outpatient dermatology clinic (NY, USA) and a private practice outp

58 Hershey Dermatology Clinic and an online survey site.

59 015, in a tertiary referral center pediatric dermatology clinic and in 2 private consultant rooms of

60 among 40 patient-parent dyads at a pediatric dermatology clinic at the Children's Hospital of Philade

61 citrant HHD were evaluated in the outpatient dermatology clinic at the Cleveland Clinic.

62 -week period at a tertiary referral academic dermatology clinic at The Hospital for Sick Children in

63 ll participants were recruited from a single dermatology clinic between April and May 2014.

64 Of these, 420 patients were evaluated in the dermatology clinic for biopsy-proven NMSC of the head an

65 is seen at a tertiary care center outpatient dermatology clinic from June 2011 through October 2012.

66 edical records from an outpatient university dermatology clinic identified patients with an acne diag

67 en September 10, 2010, and May 6, 2016, in a dermatology clinic in an academic medical center.

68 months during 2013 and 2014 at an outpatient dermatology clinic in Chicago, Illinois, with a convenie

69 er cohort study, performed in the outpatient dermatology clinic of 2 academic hospitals, included 80

70 Nine of 50 patients (18.0%) evaluated in dermatology clinic underwent biopsy to exclude skin canc

71 mical staining on formalin-fixed BCCs from a dermatology clinic were examined in masked fashion by a

72 A man in his 30s presented to the dermatology clinic with complaints of recurrent redness,

73 In each dermatology clinic, 250 consecutive adult out-patients w

74 Out of 5000 patients who visited an office dermatology clinic, clinical records of patients with sp

75 Patients were from a private practice dermatology clinic, with assessed scars representing a r

76 mination was conducted at a university-based dermatology clinic.

77 University of California, Davis, outpatient dermatology clinic.

78 ingle, urban, safety-net hospital outpatient dermatology clinic.

79 ts who would have otherwise been referred to dermatology clinic.

80 ire compared with respondents in the medical dermatology clinic: race-adjusted OR, 0.74 (95% CI, 0.56

81 Dermatology clinical practice guideline authors received

82 e payments received by physicians who author dermatology clinical practice guidelines, compare disclo

83 ot been studied among physicians who develop dermatology clinical practice guidelines.

84 Patients were identified in an outpatient dermatology clinical setting over a 6-month period (10 m

85 Dermatology clinical trials in psoriasis, atopic dermati

86 in allergy, immunology, infectious diseases, dermatology, clinical pharmacology, and pharmacogenomics

87 It is therefore important for dermatology clinicians and researchers to understand the

88 Thirty dermatology clinicians saw a total of 2770 patients with

89 placebo-controlled trial with patients from dermatology clinics at 12 VA medical centers recruited f

90 uly 1, 2011, to June 30, 2012) in outpatient dermatology clinics at an academic medical center.

91 ion other than skin cancer (controls) at the dermatology clinics at the Kirklin Clinic of the Univers

92 from an academic pigmented lesion clinic and dermatology clinics of the affiliated Veteran Affairs me

93 via flyers displayed on college campuses, at dermatology clinics, and at student health facilities.

94 are numerous barriers to achieving cosmetic dermatology competency during residency.

95 bability, 0.0025; 95% CI, 0.00020-0.030 with dermatology consult vs 0.026; 95% CI, 0.0065-0.10 withou

96 Patients were randomized to dermatology consultation (n = 40) versus standard of car

97 and 20 patients were randomized to receive a dermatology consultation (treatment group).

98 Of the 20 patients in the dermatology consultation group, 2 (10%) were diagnosed a

99 Dermatology consultation in the primary care setting imp

100 Obtaining an outpatient dermatology consultation may be a cost-effective strateg

101 Analysis was performed on dermatology consultation patients to establish a predict

102 cal diagnosis for nonexcised lesions) of FTF dermatology consultation remains higher (67%-85% agreeme

103 The expansion of the role of dermatology consultation services may improve patient ca

104 ed for any indication, for whom an inpatient dermatology consultation was requested between September

105 Of those evaluated by dermatology consultation, pseudocellulitis was diagnosed

106 logy is reliable for the triage of inpatient dermatology consultations and has the potential to impro

107 The value of inpatient dermatology consultations has traditionally been demonst

108 nosis and management; however, the impact of dermatology consultations on metrics such as hospital le

109 Multivariable modeling also showed that dermatology consultations were associated with a reducti

110 Multivariable modeling showed that dermatology consultations were associated with a reducti

111 Dermatology consultations were associated with improveme

112 To determine the association of dermatology consultations with patient care in hospitali

113 lectance confocal microscopy with a handheld dermatology-dedicated microscope can play a role in the

114 trial was conducted at a university hospital dermatology department according to the intention-to-tre

115 University hospital dermatology department affiliated with the French NF1 re

116 The patients had all been treated in the dermatology department at Hospital Universitari Germans

117 n transplant from 1990-2008 evaluated in the dermatology department for a subsequent biopsy-proven he

118 thirty-two patients who were examined at the Dermatology Department of Tokyo Medical University Hospi

119 d using the medical records of patients from dermatology departments belonging to the French Study Gr

120 ve multicenter study was conducted including dermatology departments belonging to the French Study Gr

121 iocytoid Sweet syndrome was conducted in the dermatology departments of 5 university hospitals and a

122 patients with newly diagnosed BP in 8 French dermatology departments.

123 allergy, immunology, infectious disease, and dermatology discussed the current state of our understan

124 gorically between educational practices: the dermatology elective (SMD = 1.64; 95% CI, 1.17-2.11) and

125 the extent to which the American Academy of Dermatology enforced their Administrative Regulations fo

126 edical professionals with varying degrees of dermatology experience, each of whom evaluated a minimum

127 biopsy-proven DN occurred through the latest dermatology follow-up.

128 associated with telaprevir were referred to dermatology for evaluation and treatment.

129 a European Network (GA(2) LEN), the European Dermatology Forum (EDF), and the World Allergy Organizat

130 had a seismic impact on moving investigative dermatology from a medical backwater to a scientific dis

131 of all NIH grants awarded to departments of dermatology from fiscal year 2009 to 2014.

132 y enhance many aspects of clinical trials in dermatology, from recruitment and retention of participa

133 f payments received by physicians who author dermatology guidelines and the accuracy of disclosure st

134 Three American Academy of Dermatology guidelines published from 2013 to 2016 were

135 e Parameter and the 2014 American Academy of Dermatology guidelines to highlight the basic principles

136 tutes of Health, Southern Medical University Dermatology Hospital, Doris Duke Charitable Foundation.

137 Limited evidence exists for task shifting in dermatology; however, studies from psychiatry demonstrat

138 oid Meeting, organized by the Departments of Dermatology in Lubeck and Marburg and the Institute of A

139 Medicare Advantage physician directories for dermatology in many areas substantially overestimate the

140 mmunication and imaging tools, are affecting dermatology in profound ways.

141 to lead to key discoveries in investigative dermatology, including but not limited to identifying si

142 s have shown promising results in radiology, dermatology, intensive care, diabetes, rheumatology and

143 engths and limitations that should guide the dermatology investigator's choice of assay.

144 trend in NIH funding for female and MD-only dermatology investigators.

145 Although microRNA research in psoriasis and dermatology is still relatively new, evidence is rapidly

146 For many years, The Journal of Investigative Dermatology (JID) has been a leader in our understanding

147 We identified popular dermatology journals based on Facebook likes and Twitter

148 We obtained an archived list of 102 current dermatology journals from SCImago on the World Wide Web

149 On July 17, 2012, of the 102 dermatology journals ranked by SCImago, 12.7% were prese

150 The future of dermatology lies in integrative research, in which clini

151 Secondary measures included the Children's Dermatology Life Quality Index (CDLQI) scores and genera

152 They wrote Children's Dermatology Life Quality Index (CDLQI) when they visited

153 measured quality of life with the Children's Dermatology Life Quality Index (CDLQI).

154 Index for Atopic Dermatitis (QoLIAD) and the Dermatology Life Quality Index (DLQI) are recommended fo

155 ek dosing is ineffective, with reductions in Dermatology Life Quality Index (DLQI) scores compared wi

156 a Activity Score (UAS), has correlation with Dermatology Life Quality Index (DLQI) which assesses Qua

157 Index (PASI), and secondary outcome was the Dermatology Life Quality Index (DLQI).

158 compare its measurement properties with the Dermatology Life Quality Index (DLQI).

159 (moderate certainty) quality of life (QoL) (Dermatology Life Quality Index (DLQI); MD -2.01; 95%CI -

160 oL (AE-QoL; 56.2 [18.7] and 59.9 [19.2]) and Dermatology Life Quality Index (DLQI; 14.6 [5.7] and 16.

161 9; 95% CI: 1.03-1.38), and a higher baseline dermatology life quality index (HR 1.01; 95% CI: 1.00-1.

162 more severe disease had higher scores in the dermatology life quality index (mean [standard deviation

163 e specific skin pain-related question on the Dermatology Life Quality Index (median, -1.00; range, -2

164 rms in skin-related quality of life by total Dermatology Life Quality Index (median, -4.00; range, -8

165 nt-Oriented Eczema Measure (P < 0.0001), and Dermatology Life Quality Index (P = 0.0285).

166 ith quality-of-life instruments, such as the Dermatology Life Quality Index (Spearman rank correlatio

167 amyloid A), and quality-of-life assessments (Dermatology Life Quality Index and 36-item short form he

168 Mean (SD) Dermatology Life Quality Index and Chronic Urticaria Qua

169 Eczema Measure, pruritus score, sleep score, Dermatology Life Quality Index and IgE.

170 The difference in Dermatology Life Quality Index between the two groups wa

171 , the mean +/- standard deviation decline in Dermatology Life Quality Index was 1.64 +/- 4.34 compare

172 kinumab demonstrated improvements in SCORAD, Dermatology Life Quality Index, and pruritus numeric rat

173 s measures (Patient-Oriented Eczema Measure, Dermatology Life Quality Index, Numeric Rating Scale pru

174 al Anxiety and Depression Scale, and (4) the Dermatology Life Quality Index.

175 of interest was the HRQOL as measured by the Dermatology Life Quality Index.

176 rtake an MR analysis, with examples from the dermatology literature.

177 s comparing IPNI and CPNI are limited in the dermatology literature.

178 We hypothesized that patients in the dermatology medical setting would prefer professional at

179 based study, performed at a national medical dermatology meeting in Itasca, Illinois, in 2012, includ

180 n this issue of the Journal of Investigative Dermatology, Meylan et al. present evidence from a prosp

181 The benefits of free samples in dermatology must be weighed against potential negative e

182 participants were practicing or training in dermatology (n = 144 [91.1%]).

183 The American Academy of Dermatology-National Psoriasis Foundation guidelines rec

184 ermatology organizations included dermRounds Dermatology Network (11 251 likes on Facebook and 2900 f

185 The mean payments for the subspecialties of dermatology, neurosurgery, orthopedic surgery, and urolo

186 nd regularly followed up at the divisions of dermatology of several main hospitals in the Northern It

187 (NY, USA) and a private practice outpatient dermatology office in Newport Beach (CA, USA).

188 more than 60 clinical variables relating to dermatology, ophthalmology, and neurology have been meas

189 Use of high-dose lasers and light devices in dermatology, ophthalmology, oncology, and dentistry are

190 identified professional and patient-centered dermatology organization activity on social networks thr

191 Popular professional dermatology organizations included dermRounds Dermatolog

192 Patient-centered and professional dermatology organizations use social networking sites; h

193 K on the face were recruited in a university dermatology outpatient clinic from 2015 to 2016, and 32

194 This study was a case series performed at a dermatology outpatient clinic of 3 patients with severe

195 cally dispersed US private and institutional dermatology outpatient clinical practices focused on cos

196 Patients were from plastic surgery and dermatology outpatient clinics in the United States and

197 ge-matched male controls without acne from a dermatology outpatient department of a tertiary care ins

198 008 and September 2009 were recruited from a dermatology outpatient department.

199 bo-controlled randomized clinical trial at a dermatology outpatient practice of an urban academic med

200 or serving as biomarkers and therapeutics in dermatology over the next decade.

201 ithms in published radiology, ophthalmology, dermatology, pathology, gastroenterology, and cardiology

202 The most popular dermatology patient-centered organizations were the Skin

203 tional, anonymous survey by English-speaking dermatology patients (aged 18 years or older) at general

204 dents were medical, surgical, and wound care dermatology patients, respectively.

205 n the general population of immunosuppressed dermatology patients.

206 An expert panel in psoriasis, pediatric dermatology, pediatric rheumatology, pediatric gastroent

207 n pediatric dermatology, procedural/cosmetic dermatology, plastic surgery, scars, wound healing, acne

208 an international multidisciplinary team from dermatology, plastic surgery, surgical oncology, emergen

209 The American Academy of Dermatology policies may benefit from stricter enforceme

210 , through December 31, 2000, in a university dermatology practice and its affiliated Department of Ve

211 cal record review carried out in a pediatric dermatology practice at an academic institution of patie

212 Women aged 18 to 45 years visiting a dermatology practice completed anonymous surveys assessi

213 and EVD images of skin tumors from a private dermatology practice from March 1 to September 30, 2013.

214 We performed a prospective dermatology practice-based study using questionnaires an

215 er 80s (patient 2)-were treated in a private dermatology practice.

216 2, 2009, to December 31, 2012) from a single dermatology practice.

217 g consensus on standards for skin imaging in dermatology practice.

218 outpatient dermatology centers and 1 private dermatology practice.

219 g consensus on standards for skin imaging in dermatology practice.

220 An online survey in academic dermatology practices among PDs of US dermatology reside

221 rol study performed in multicenter pediatric dermatology practices in the United States recruited 132

222 as conducted of patient-generated reviews of dermatology practices on 2 consumer review platforms.

223 A total of 518 reviews from 45 dermatology practices on Yelp and 4921 reviews from 45 d

224 elanoma patients from regional hospitals and dermatology practices.

225 A panel of national experts in pediatric dermatology, procedural/cosmetic dermatology, plastic su

226 ould not be required to perform any cosmetic dermatology procedures.

227 The dermatology profession needs to understand disease manag

228 y practices on Yelp and 4921 reviews from 45 dermatology providers on ZocDoc were collected from 3 ge

229 ted relying on consumer websites to identify dermatology providers.

230 Dermatology QOL instruments may measure general skin-spe

231 January 1, 2007, and December 31, 2013, at a dermatology referral center at a single institution.

232 n cancer training and screening by PCPs with dermatology referral patterns and rates of skin biopsies

233 n prescription acne treatment at the time of dermatology referral.

234 ntion revealed no significant differences in dermatology referrals overall and those for presumptive

235 tion of significantly fewer postintervention dermatology referrals that lacked specific diagnoses (25

236 Proportion of dermatology referrals, subsequent skin biopsies, and PCP

237 le data available regarding the diversity of dermatology research cohorts with respect to sex, race,

238 al of 1292 NIH-funded grants were awarded to dermatology research from fiscal year 2009 through 2014.

239 for maintaining their presence in NIH-funded dermatology research.

240 Surgical training in dermatology residencies has increased, and there is grow

241 om PDs were received from 53 of 114 (46%) US dermatology residency programs.

242 ademic dermatology practices among PDs of US dermatology residency programs.

243 address patient safety gaps occurring during dermatology residency.

244 ns in the CSD among Texas dermatologists and dermatology residents and patient registrations among CS

245 of elliptical excisions performed by senior dermatology residents applying for procedural or Mohs su

246 Self-reported rates of dermatology residents committing errors, identifying loc

247 Many dermatology residents enter the workforce planning to pr

248 g in Itasca, Illinois, in 2012, included 142 dermatology residents from 44 residency programs in the

249 ions of the CSD and among dermatologists and dermatology residents in Texas from April 1, 2011, throu

250 Senior dermatology residents preparing for surgery fellowships

251 Of surveyed dermatology residents, 45.2% have failed to report needl

252 d-certified dermatologists, 118 (23.1%) were dermatology residents, and 83 (16.2%) were general pract

253 re either certified dermatologists or senior dermatology residents.

254 Wound care and medical dermatology respondents preferred professional attire co

255 rt in this issue of Journal of Investigative Dermatology reveals a role for IL-17 and IFN-gamma, sign

256 failure or signs of recurrence at the 3-year dermatology review.

257 m the outpatient clinic at the Department of Dermatology, Roskilde Hospital, and 326 patients with HS

258 It is a joint initiative of the Dermatology Section of the European Academy of Allergy a

259 ries study included patients referred to the Dermatology Service at Memorial Sloan Kettering Cancer C

260 this case series, 2 patients referred to the dermatology service of an academic tertiary care hospita

261 tor-blinded randomized clinical trial at the dermatology service of an urban university medical cente

262 arch 1, 2016, through March 31, 2017, at the Dermatology Service of the Memorial Sloan Kettering Canc

263 ts affiliated Department of Veterans Affairs dermatology service.

264 red from remote sites of primary care to the dermatology services of 2 VA medical facilities for ambu

265 quired to travel farther distances to access dermatology services.

266 tients who were identified in the outpatient dermatology setting were found to have MBAITs on clinica

267 ly 20 of 53 (38%) PDs believed that cosmetic dermatology should be a necessary aspect of residency tr

268 The observation that 90% of published dermatology SRs are of very low quality is alarming.

269 ifiable exposures and outcomes, including in dermatology, such as between smoking and psoriasis.

270 l clinic settings, though respondents in the dermatology surgery clinic were less likely to prefer pr

271 r professional attire, while patients in the dermatology surgical and wound care setting would prefer

272 t population presenting to the Department of Dermatology surgical unit at Wake Forest University Bapt

273 the need for programs that promote targeted dermatology surveillance for all OTRs, regardless of rac

274 Compared with in-person dermatology, teledermatology served more patients younge

275 In dermatology, the development of objective, standardized

276 In the field of dermatology there is a need for high-quality evidence in

277 the most commonly prescribed medications in dermatology, there are limited data on steroid-related s

278 For example, in the field of dermatology, these approaches have been used to develop

279 l of the American Academy of Dermatology and Dermatology Times, respectively.

280 t 3 programs (94%) offered hands-on cosmetic dermatology training using botulinum toxin, and 47 of 53

281 ost every program provides hands-on cosmetic dermatology training, there are barriers to training, in

282 d products, and PD attitudes toward cosmetic dermatology training.

283 e cyclosporine, who presented to a specialty dermatology transplant clinic with multiple, recurrent,

284 r of female investigators with NIH grants in dermatology trended down significantly compared with the

285 ntly, no gold standard of outcome choice for dermatology trials and reviews exists.

286 Cochrane Skin systematic reviews and the 220 dermatology trials included.

287 bserver-blinded clinical study at a tertiary dermatology university hospital clinic enrolled patients

288 of 55 patients treated at the Department of Dermatology, University Hospital of Schleswig-Holstein,

289 ntified patients with an acne diagnosis at a dermatology visit in the past 3 months who were prescrib

290 nguages and were not present for a scheduled dermatology visit.

291 Rates of dermatology visits by patients affiliated with primary c

292 rom 73.5 to 3.0 days compared with in-person dermatology visits.

293 rcely used within the field of investigative dermatology, we aim to highlight CyTOF's utility and dem

294 All NIH-funded principal investigators in dermatology were categorized by their academic degree an

295 standards for camera-based digital images in dermatology were identified.

296 re who underwent review at the Department of Dermatology, Westmead Hospital.

297 tment at a university hospital department of dermatology with ustekinumab according to the dosing reg

298 tient clinical practices focused on cosmetic dermatology, with a total of 23 dermatologists.

299 igence is becoming increasingly important in dermatology, with studies reporting accuracy matching or

300 methodological framework to develop COSs in dermatology, with the ultimate goal of better decision m

301 ith HS were recruited from the Department of Dermatology, Zealand University Hospital, Roskilde, Denm